Back to Journals » Drug Design, Development and Therapy » Volume 12
Original Research
Risk of hematologic toxicities with programmed cell death-1 inhibitors in cancer patients: a meta-analysis of current studies
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
15,699 | Dovepress* | 14,068+ | 1,157 | 15,225 | |
PubMed Central* | 1,631 | 564 | 2,195 | ||
Totals | 15,699 | 1,721 | 17,420 | ||
*Since 8 June 2018 |
View citations on PubMed Central and Google Scholar